Point is, @tak1 would rather discredit the poster, than attempt to employ critical thought and refute the assertions made about market opportunity and chance of commercial/clinical success.
IMU was a sell when Merck bailed, if not before.
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant, page-52
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.060(5.26%) |
Mkt cap ! $210.2M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.23 | $1.15 | $99.88K | 84.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3832 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 2533 | 1 |
View Market Depth
| Last trade - 14.34pm 23/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |